The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

Clinical trial NCT04084860 · RECRUITING

Trial details

NCT number: NCT04084860
Sponsor: New York State Psychiatric Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alcohol Use Disorder

Start date: 2019-11-08
Primary completion: 2024-08-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.